SK Chemicals drugs
Scope
Date
~
-
Pension funds
NPS picks tech, electronics as its favorite local stocks in 2023
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, picked information tech, electric and electronic s...
Jan 17, 2024 (Gmt+09:00)
-
Batteries
SK On signs tech transfer with Solid Power
SK On Co., a battery affiliate of South Korea's SK Group, announced on Wednesday that it has signed a technology transfer agreement with the US-ba...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Energy
SK Gas, SK D&D to venture into US ESS market with Apex
SK Gas Ltd. and SK D&D Co. will build their first-ever energy storage system (ESS) facility in the US that can power 39,000 homes daily via a jo...
Jan 17, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Lotte Chem’s sale of Pakistani PTA unit falls through
Lotte Chemical Corp.'s plan to sell off its Pakistani PTA subsidiary to local chemicals producer Lucky Core Industries Ltd. has collapsed, a year af...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Artificial intelligence
SK Networks invests $19 mn in AI startup Upstage
South Korea's SK Networks Co. announced on Friday that it has invested 25 billion won ($19.02 million) in the domestic artificial intelligence (AI...
Jan 12, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
SK Telecom considers adding LLM to iPhone recording app
LAS VEGAS -- SK Telecom Co. is considering adding a large language model (LLM) to its iPhone call-recording app for the first time in the industry, ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Debt financing
SK Hynix raises $1.5 bn in foreign bonds amid high demand
SK Hynix Inc., the world’s second-largest memory chipmaker, has raised $1.5 billion in foreign currency bonds, with the debt offering four tim...
Jan 10, 2024 (Gmt+09:00)
-
Batteries
SK On to develop large-size cylindrical battery with 4680 form factor
SK On Co., an affiliate of South Korea’s SK Group, will work on the development of a large-size cylindrical battery with the 4680 form factor ...
Jan 07, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom, Naver, AfreecaTV to introduce AI in sportscasting
SK Telecom Co., Naver Corp., and AfreecaTV have joined forces to introduce artificial intelligence (AI) technology in the sports broadcasting field....
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Korean chipmakers
Memory chipmaker SK Hynix to raise $1 bn in dollar bonds
South Korea’s SK Hynix Inc., the world’s second-largest memory chipmaker, is seeking to raise about $1 billion in dollar bonds.The chipm...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Korean chipmakers
Samsung, SK Hynix join forces with foreign rivals to win AI chip war
South Korea’s two chip giants Samsung Electronics Co. and SK Hynix Inc. are expected to further deepen ties with rivals and customers from aro...
Dec 31, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korea’s besieged mobile carriers grapple with OTT players’ rate hikes
South Korea’s telecommunications companies, besieged by the onslaught of foreign over-the-top (OTT) players such as Netflix and YouTube, are g...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Chemical Industry
Aekyung Chemical acquires LG Chem Vietnam's plasticizer subsidiary
South Korean consumer goods company Aekyung Chemical announced on Friday that it has acquired VPCHEM, the Vietnam subsidiary of LG Chem Ltd., a comp...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, HK inno.N to co-market Kanarb, K-CAB
South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...
Dec 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Icure wins $2.85 mn lidocaine cataplasm order from Guatemala
South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...
Dec 19, 2023 (Gmt+09:00)
-
Korean chipmakers
Chip cycle hits rock bottom but uncertainty lingers: Chey
The global semiconductor market has hit "rock bottom" but uncertainties remain high amid growing protectionism and lingering concerns about China&rs...
Dec 19, 2023 (Gmt+09:00)